Popular Peptides

Semaglutide is a synthetic glucagon-like peptide-1 receptor agonist (GLP-1RA) originally developed for research into type 2 diabetes and obesity. It mimics the activity of endogenous GLP-1, a hormone that regulates glucose metabolism and appetite. By engaging GLP-1 receptors, Semaglutide enhances insulin secretion, reduces glucagon output, slows gastric emptying, and increases satiety, supporting improvements in metabolic balance and body weight regulation.

Semaglutide is a synthetic glucagon-like peptide-1 receptor agonist (GLP-1RA) originally developed for research into type 2 diabetes and obesity. It mimics the activity of endogenous GLP-1, a hormone that regulates glucose metabolism and appetite. By engaging GLP-1 receptors, Semaglutide enhances insulin secretion, reduces glucagon output, slows gastric emptying, and increases satiety, supporting improvements in metabolic balance and body weight regulation.

Semaglutide is a synthetic glucagon-like peptide-1 receptor agonist (GLP-1RA) originally developed for research into type 2 diabetes and obesity. It mimics the activity of endogenous GLP-1, a hormone that regulates glucose metabolism and appetite. By engaging GLP-1 receptors, Semaglutide enhances insulin secretion, reduces glucagon output, slows gastric emptying, and increases satiety, supporting improvements in metabolic balance and body weight regulation.

Sermorelin (GRF 1–29) is a synthetic peptide fragment corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH). It has been investigated in research for its role in endocrine signaling and regulation of growth hormone pathways. Scientific studies focus on its ability to engage pituitary GHRH receptors and to serve as a tool in exploring age-related changes in growth hormone axis biology.

Sermorelin (GRF 1–29) is a synthetic peptide fragment corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH). It has been investigated in research for its role in endocrine signaling and regulation of growth hormone pathways. Scientific studies focus on its ability to engage pituitary GHRH receptors and to serve as a tool in exploring age-related changes in growth hormone axis biology.

TB-500 is the synthetic fragment of Thymosin Beta-4 (Tβ4), a naturally occurring peptide found in nearly all human and animal cells. Tβ4 has been investigated for its role in cell migration, tissue remodeling, angiogenesis, and inflammation modulation. TB-500 has been developed to explore these properties in a research context, providing a stable and bioavailable model peptide for scientific studies.